<DOC>
	<DOC>NCT02896413</DOC>
	<brief_summary>Surgical stress and anesthesia may cause immunosuppression in immunocompromised cancer patients. The natural killer (NK) cell is a critical part of anti-tumor immunity. Dexmedetomidine has sympatholytic effect and preserves NK cell function. This study investigate the effect of dexmedetomidine on immune suppression and postoperative outcomes in patients undergoing uterine cancer resection.</brief_summary>
	<brief_title>The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection</brief_title>
	<detailed_description />
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>patient between 20 and 70 of age with ASA physical status ⅠⅢ patient scheduled for uterine cancer surgery ASA physical status Ⅳ severe hepatorenal disease infection metastasis to other organ problem with communication</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>